Long‐term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma

Saved in:
Bibliographic Details
Main Authors: Lin Lu, Lei Xia, Xinhong Shi, Yingying Dai, Zipeng Wu, Yue Shi, Yingying Jiang, Yiling Liu, Yuxin Ma, Shuyi Hu, Ruofan Yu, Tianyi Liu, Caolu Liu, Jingwen Li, Guochun Cao, Delin Liu, Fei Yan, Jinghua Zhu, Xiaohua Wang, Lijun Zhao, Cheng Chen
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Clinical and Translational Medicine
Online Access:https://doi.org/10.1002/ctm2.70377
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849683328636026880
author Lin Lu
Lei Xia
Xinhong Shi
Yingying Dai
Zipeng Wu
Yue Shi
Yingying Jiang
Yiling Liu
Yuxin Ma
Shuyi Hu
Ruofan Yu
Tianyi Liu
Caolu Liu
Jingwen Li
Guochun Cao
Delin Liu
Fei Yan
Jinghua Zhu
Xiaohua Wang
Lijun Zhao
Cheng Chen
author_facet Lin Lu
Lei Xia
Xinhong Shi
Yingying Dai
Zipeng Wu
Yue Shi
Yingying Jiang
Yiling Liu
Yuxin Ma
Shuyi Hu
Ruofan Yu
Tianyi Liu
Caolu Liu
Jingwen Li
Guochun Cao
Delin Liu
Fei Yan
Jinghua Zhu
Xiaohua Wang
Lijun Zhao
Cheng Chen
author_sort Lin Lu
collection DOAJ
format Article
id doaj-art-0a0be9855b904e538b1efe413365b60d
institution DOAJ
issn 2001-1326
language English
publishDate 2025-06-01
publisher Wiley
record_format Article
series Clinical and Translational Medicine
spelling doaj-art-0a0be9855b904e538b1efe413365b60d2025-08-20T03:23:56ZengWileyClinical and Translational Medicine2001-13262025-06-01156n/an/a10.1002/ctm2.70377Long‐term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinomaLin Lu0Lei Xia1Xinhong Shi2Yingying Dai3Zipeng Wu4Yue Shi5Yingying Jiang6Yiling Liu7Yuxin Ma8Shuyi Hu9Ruofan Yu10Tianyi Liu11Caolu Liu12Jingwen Li13Guochun Cao14Delin Liu15Fei Yan16Jinghua Zhu17Xiaohua Wang18Lijun Zhao19Cheng Chen20Department of Radiation Oncology The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Pathology The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Medical Oncology The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Radiation Oncology The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Medical Oncology The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Medical Oncology The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Oncology Geriatric Hospital of Nanjing Medical University Nanjing ChinaDepartment of Oncology Sichuan Second Hospital of Traditional Chinese Medicine Chengdu ChinaDepartment of Medical Oncology The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Medical Oncology The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Medical Oncology The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Radiation Oncology The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaNanjing Medical University Nanjing ChinaNanjing Medical University Nanjing ChinaDepartment of Medical Oncology The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Medical Oncology The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Medical Oncology The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Medical Oncology The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Medical Oncology The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Radiation Oncology The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing ChinaDepartment of Radiation Oncology The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing Chinahttps://doi.org/10.1002/ctm2.70377
spellingShingle Lin Lu
Lei Xia
Xinhong Shi
Yingying Dai
Zipeng Wu
Yue Shi
Yingying Jiang
Yiling Liu
Yuxin Ma
Shuyi Hu
Ruofan Yu
Tianyi Liu
Caolu Liu
Jingwen Li
Guochun Cao
Delin Liu
Fei Yan
Jinghua Zhu
Xiaohua Wang
Lijun Zhao
Cheng Chen
Long‐term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma
Clinical and Translational Medicine
title Long‐term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma
title_full Long‐term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma
title_fullStr Long‐term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma
title_full_unstemmed Long‐term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma
title_short Long‐term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma
title_sort long term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma
url https://doi.org/10.1002/ctm2.70377
work_keys_str_mv AT linlu longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT leixia longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT xinhongshi longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT yingyingdai longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT zipengwu longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT yueshi longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT yingyingjiang longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT yilingliu longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT yuxinma longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT shuyihu longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT ruofanyu longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT tianyiliu longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT caoluliu longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT jingwenli longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT guochuncao longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT delinliu longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT feiyan longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT jinghuazhu longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT xiaohuawang longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT lijunzhao longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma
AT chengchen longtermsurvivalandassociationofneoadjuvantchemotherapywithorwithoutimmunotherapyinresectableesophagealsquamouscellcarcinoma